Literature DB >> 6413629

Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment.

V T Turitto, H J Weiss, H R Baumgartner.   

Abstract

The adhesion of platelets to subendothelium exposed to flowing blood involves two distinct morphological stages: (1) platelet contact (C), the initial attachment of unspread, discoid platelets to the subendothelium, and (2) spread platelets (S), the attachment that results as contact platelets spread on the surface and become more firmly bound to it. A defect in either initial platelet attachment or platelet spreading can result in reduced levels of platelet adhesion (C + S). The combined observation of decreased platelet adhesion (C + S) and increased platelet contact (C) has been previously utilized to conclude that a defect exists in the ability of platelets to spread on subendothelium in von Willebrand's disease. In this present investigation, we demonstrate, by modeling the contact and spreading stages of platelet adhesion as a classic set of reactions in series, that the combination of reduced adhesion (C + S) and increased contact (C) is inconclusive with regard to the nature of the adhesion defect in von Willebrand's disease. Decreased adhesion (C + S) coupled with increased platelet contact (C) can result from either decreased rates of initial attachment or decreased rates of spreading. In fact, given the complexity of the temporal behavior of platelet contact (C) and platelet spreading (S), and the relatively small fraction (less than 10%) of the platelets that are in contact (C) at any time, we conclude that a determination of the nature of the adhesion (C + S) defect in von Willebrand's disease is not statistically feasible under conditions in which both contact and spreading occur simultaneously. Experiments were conducted in which blood anticoagulated with EDTA was exposed to subendothelium digested with alpha-chymotrypsin for periods of 10 and 40 min. Under such conditions, platelet spreading (S) was substantially inhibited so that the predominant platelet interaction (greater than 80%) on the subendothelium was platelet contact (C). Values of platelet adhesion (C + S) in von Willebrand's disease were significantly reduced (p less than 0.05) compared with normal values at both exposure times. Thus we conclude that the defect in platelet adhesion (C + S) in von Willebrand's disease appears to be associated with a reduced ability of platelets to attach to the surface rather than their inability to spread on the surface.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413629

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets.

Authors:  J G White; M D Krumwiede; G Escolar
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

Authors:  H J Weiss; J Hawiger; Z M Ruggeri; V T Turitto; P Thiagarajan; T Hoffmann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.

Authors:  J B Lawrence; W S Kramer; L P McKeown; S B Williams; H R Gralnick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Prelabeled glycoprotein Ib/IX receptors are not cleared from exposed surfaces of thrombin-activated platelets.

Authors:  J G White; M D Krumwiede; D Cocking-Johnson; G Escolar
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Platelet activation due to hemodynamic shear stresses: damage accumulation model and comparison to in vitro measurements.

Authors:  Matteo Nobili; Jawaad Sheriff; Umberto Morbiducci; Alberto Redaelli; Danny Bluestein
Journal:  ASAIO J       Date:  2008 Jan-Feb       Impact factor: 2.872

6.  Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype.

Authors:  T C Nichols; D A Bellinger; K E Davis; G G Koch; R L Reddick; M S Read; J Rapacz; J Hasler-Rapacz; K M Brinkhous; T R Griggs
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

7.  Glanzmann's thrombasthenia with mild von Willebrand's disease.

Authors:  R Nounou; D Spence
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

8.  Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.

Authors:  M Lehmann; K Ashworth; M Manco-Johnson; J Di Paola; K B Neeves; C J Ng
Journal:  J Thromb Haemost       Date:  2017-11-23       Impact factor: 5.824

9.  Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation.

Authors:  S M Slack; L K Jennings; V T Turitto
Journal:  Ann Biomed Eng       Date:  1994 Nov-Dec       Impact factor: 3.934

10.  Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.

Authors:  W P Houdijk; K S Sakariassen; P F Nievelstein; J J Sixma
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.